You just read:

Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer

News provided by

EMD Serono

May 12, 2015, 06:25 ET